Medical research

New COVID jab offers hope for immunocompromised

A COVID vaccine that provokes an immune response through white blood cells has showed promise in trials, according to research Tuesday that provides new hope for people with compromised immune systems.

Alzheimer's disease & dementia

Trial begins of nasal vaccine for Alzheimer's disease

(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research.

Diseases, Conditions, Syndromes

Ebola vaccine to begin human trials

The University of Oxford have begun recruiting for a Phase I trial to test an Ebola vaccine in human volunteers—with the first vaccinations having already taken place.

page 1 from 40